Imran H Iftikhar1, Camilla M Hoyos2, Craig L Phillips2,3, Ulysses J Magalang4. 1. Division of Pulmonary, Critical Care, and Sleep Medicine, University of South Carolina School of Medicine, Columbia, SC. 2. Woolcock Institute of Medical Research, Central Clinical School, University of Sydney, Australia. 3. Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, Australia. 4. Divison of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Ohio State University Wexner Medical Center, Columbus, OH.
Abstract
OBJECTIVE: We sought to conduct an updated meta-analysis of randomized controlled trials (RCTs) on the effect of continuous positive airway pressure (CPAP) on insulin resistance, as measured by homeostasis model assessment of insulin resistance (HOMA-IR), visceral abdominal fat (VAF), and adiponectin. Additionally, we performed a separate meta-analysis and meta-regression of studies on the association of insulin resistance and obstructive sleep apnea (OSA). METHODS: All included studies were searched from PubMed (from conception to March 15, 2014). Data were pooled across all included RCTs as the mean difference in HOMA-IR and VAF, and as the standardized mean difference in the case of adiponectin analysis. From the included case-control studies, data on the difference of HOMA-IR between cases and controls were pooled across all studies, as the standardized mean difference (SMD). RESULTS: There was a significant difference in HOMA-IR (-0.43 [95% CIs: -0.75 to -0.11], p = 0.008) between CPAP treated and non CPAP treated participants. However, there was no significant difference in VAF or adiponectin; (-47.93 [95% CI: -112.58 to 16.72], p = 0.14) and (-0.06 [95% CI: -0.28 to 0.15], p = 0.56), respectively. Meta-analysis of 16 case-control studies showed a pooled SMD in HOMA-IR of 0.51 (95% CI: 0.28 to 0.75), p ≤ 0.001, between cases and controls. CONCLUSIONS: The results of our meta-analyses show that CPAP has a favorable effect on insulin resistance. This effect is not associated with any significant changes in total adiponectin levels or amount of VAF. Our findings also confirm a significant association between OSA and insulin resistance.
OBJECTIVE: We sought to conduct an updated meta-analysis of randomized controlled trials (RCTs) on the effect of continuous positive airway pressure (CPAP) on insulin resistance, as measured by homeostasis model assessment of insulin resistance (HOMA-IR), visceral abdominal fat (VAF), and adiponectin. Additionally, we performed a separate meta-analysis and meta-regression of studies on the association of insulin resistance and obstructive sleep apnea (OSA). METHODS: All included studies were searched from PubMed (from conception to March 15, 2014). Data were pooled across all included RCTs as the mean difference in HOMA-IR and VAF, and as the standardized mean difference in the case of adiponectin analysis. From the included case-control studies, data on the difference of HOMA-IR between cases and controls were pooled across all studies, as the standardized mean difference (SMD). RESULTS: There was a significant difference in HOMA-IR (-0.43 [95% CIs: -0.75 to -0.11], p = 0.008) between CPAP treated and non CPAP treated participants. However, there was no significant difference in VAF or adiponectin; (-47.93 [95% CI: -112.58 to 16.72], p = 0.14) and (-0.06 [95% CI: -0.28 to 0.15], p = 0.56), respectively. Meta-analysis of 16 case-control studies showed a pooled SMD in HOMA-IR of 0.51 (95% CI: 0.28 to 0.75), p ≤ 0.001, between cases and controls. CONCLUSIONS: The results of our meta-analyses show that CPAP has a favorable effect on insulin resistance. This effect is not associated with any significant changes in total adiponectin levels or amount of VAF. Our findings also confirm a significant association between OSA and insulin resistance.
Authors: Stuart F Quan; Rohit Budhiraja; Denise P Clarke; James L Goodwin; Daniel J Gottlieb; Deborah A Nichols; Richard D Simon; Terry W Smith; James K Walsh; Clete A Kushida Journal: J Clin Sleep Med Date: 2013-10-15 Impact factor: 4.062
Authors: B Masserini; P S Morpurgo; F Donadio; C Baldessari; R Bossi; P Beck-Peccoz; E Orsi Journal: J Endocrinol Invest Date: 2006-09 Impact factor: 4.256
Authors: Igor Alexander Harsch; Simin Pour Schahin; Kerstin Brückner; Martin Radespiel-Tröger; Florian S Fuchs; Eckhart Georg Hahn; Peter Christopher Konturek; Tobias Lohmann; Joachim Hans Ficker Journal: Respiration Date: 2004 May-Jun Impact factor: 3.580
Authors: Steven R Coughlin; Lynn Mawdsley; Julie A Mugarza; Peter M A Calverley; John P H Wilding Journal: Eur Heart J Date: 2004-05 Impact factor: 29.983
Authors: Agata Gabryelska; Bartosz Szmyd; Janusz Szemraj; Robert Stawski; Marcin Sochal; Piotr Białasiewicz Journal: J Clin Sleep Med Date: 2020-10-15 Impact factor: 4.062
Authors: Octavian C Ioachimescu; Jeremy Anthony; Tina Constantin; Mary-Margaret Ciavatta; Kandace McCarver; Mary Ellen Sweeney Journal: J Clin Sleep Med Date: 2017-03-15 Impact factor: 4.062